• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖依赖性胰岛素多肽(GIP)的 Tyr1 和 Ile7 赋予其对 GIP 和胰高血糖素样肽-1 受体的不同配体选择性。

Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.

机构信息

Graduate School of Medicine, Korea University, Seoul 136-705, Korea.

出版信息

Mol Cells. 2010 Aug;30(2):149-54. doi: 10.1007/s10059-010-0100-5. Epub 2010 Aug 19.

DOI:10.1007/s10059-010-0100-5
PMID:20799012
Abstract

Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic beta cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall alpha-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr(1), Ile(7), Asp(15), and His(18) were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr(1) and/or Ile(7) in the N-terminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp(15) and/or His(18) in the central alpha-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His(1) and Ile/Thr(7) of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R.

摘要

胰高血糖素样肽-1(GLP-1)和葡萄糖依赖性胰岛素促分泌多肽(GIP)是响应食物摄入而释放的肠促胰岛素激素,通过其独特但相关的 G 蛋白偶联受体 GLP1R 和 GIPR 增强胰腺β细胞的胰岛素分泌。虽然 GLP-1 和 GIP 在其 N 端序列和整体α-螺旋结构上具有相似性,但 GLP-1 不与 GIPR 结合,反之亦然。为了确定这些肽配体的哪些氨基酸残基负责与各自的受体特异性相互作用,我们生成了突变的 GIP,其中几个 GLP-1 特异性氨基酸残基被原始氨基酸取代。使用共转染 GLP1R 或 GIPR 表达质粒和 cAMP 反应元件驱动的荧光素酶(CRE-luc)报告质粒的 HEK293 细胞来检查突变配体的效力。一个突变的 GIP 肽,其中 Tyr(1)、Ile(7)、Asp(15)和 His(18)分别被 His、Thr、Glu 和 Ala 取代,能够以中等效力激活 GLP1R 和 GIPR。在这个突变肽的 N 端部分取代原始的 Tyr(1)和/或 Ile(7)允许完全激活 GIPR,但不能激活 GLP1R。然而,在中央α-螺旋区域重新引入 Asp(15)和/或 His(18)并没有显著改变配体的效力。这些结果表明,GIP/GLP-1 肽的 Tyr/His(1)和 Ile/Thr(7)赋予 GIPR 和 GLP1R 对配体的不同选择性。

相似文献

1
Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.葡萄糖依赖性胰岛素多肽(GIP)的 Tyr1 和 Ile7 赋予其对 GIP 和胰高血糖素样肽-1 受体的不同配体选择性。
Mol Cells. 2010 Aug;30(2):149-54. doi: 10.1007/s10059-010-0100-5. Epub 2010 Aug 19.
2
Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.在胰高血糖素样肽-1(GLP-1)受体核心处进化上保守的残基赋予配体诱导的受体激活。
J Biol Chem. 2012 Feb 3;287(6):3873-84. doi: 10.1074/jbc.M111.276808. Epub 2011 Nov 21.
3
Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.葡萄糖依赖性促胰岛素多肽与胰高血糖素样肽1受体信号传导对小鼠β细胞存活的不同重要性
Gastroenterology. 2009 Dec;137(6):2146-57. doi: 10.1053/j.gastro.2009.09.004. Epub 2009 Sep 17.
4
A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.一种双重 GLP-1/GIP 受体激动剂不会在其受体上拮抗胰高血糖素,而是可能在 GLP-1 受体上作为一种偏向激动剂发挥作用。
Int J Mol Sci. 2019 Jul 19;20(14):3532. doi: 10.3390/ijms20143532.
5
Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.鲜味受体激活通过胰高血糖素样肽-2 释放增加大鼠十二指肠碳酸氢盐分泌。
J Pharmacol Exp Ther. 2011 Nov;339(2):464-73. doi: 10.1124/jpet.111.184788. Epub 2011 Aug 16.
6
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.一种新型的 GIP-oxyntomodulin 杂合肽通过 GIP、胰高血糖素和 GLP-1 受体发挥作用,具有减肥和抗糖尿病作用。
Biochem Pharmacol. 2013 Jun 1;85(11):1655-62. doi: 10.1016/j.bcp.2013.03.009. Epub 2013 Mar 18.
7
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.优化的 GIP 类似物通过 GIPR 激动作用而不是拮抗作用促进小鼠体重降低。
Mol Metab. 2019 Feb;20:51-62. doi: 10.1016/j.molmet.2018.12.001. Epub 2018 Dec 5.
8
Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.在 HEK-293 细胞中表达时,葡萄糖依赖性胰岛素释放多肽受体/胰高血糖素样肽-1 受体异源二聚体对细胞信号转导的差异影响。
Pharmacol Res Perspect. 2022 Oct;10(5):e01013. doi: 10.1002/prp2.1013.
9
Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.GIP 和 GLP-1 受体的单肽、双肽和三肽激动剂的药理学特性。
Biochem Pharmacol. 2020 Jul;177:114001. doi: 10.1016/j.bcp.2020.114001. Epub 2020 Apr 29.
10
The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.GIP受体比GLP-1受体表现出更高的基础活性,但不能有效地募集GRK2或β-arrestin 3。
PLoS One. 2014 Sep 5;9(9):e106890. doi: 10.1371/journal.pone.0106890. eCollection 2014.

引用本文的文献

1
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP.从替尔泊肽设计双重 GLP-1R/GIPR 激动剂:比较替尔泊肽、GLP-1 和 GIP 之间的残基。
Drug Des Devel Ther. 2022 May 25;16:1547-1559. doi: 10.2147/DDDT.S358989. eCollection 2022.
2
Genetics of Acromegaly and Gigantism.肢端肥大症和巨人症的遗传学
J Clin Med. 2021 Mar 29;10(7):1377. doi: 10.3390/jcm10071377.
3
Glucagon-like peptide 1 (GLP-1).胰高血糖素样肽 1(GLP-1)。
Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30.
4
Evolutionary and Comparative Genomics to Drive Rational Drug Design, with Particular Focus on Neuropeptide Seven-Transmembrane Receptors.进化与比较基因组学推动合理药物设计,特别关注神经肽七跨膜受体。
Biomol Ther (Seoul). 2017 Jan 1;25(1):57-68. doi: 10.4062/biomolther.2016.199.
5
Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.由胰高血糖素样肽-1(GLP-1)受体核心结构域中进化保守残基形成的配体结合口袋。
J Biol Chem. 2015 Feb 27;290(9):5696-706. doi: 10.1074/jbc.M114.612606. Epub 2015 Jan 5.
6
A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth.一种新型长效胰高血糖素样肽-1 激动剂,具有改善的胰岛素分泌和β细胞生长作用。
Endocrinol Metab (Seoul). 2014 Sep;29(3):320-7. doi: 10.3803/EnM.2014.29.3.320. Epub 2014 Sep 25.
7
A novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebrates.一种新型的胰高血糖素相关肽 (GCRP) 及其受体 GCRPR 解释了脊椎动物中其家族成员的共同进化。
PLoS One. 2013 Jun 11;8(6):e65420. doi: 10.1371/journal.pone.0065420. Print 2013.
8
Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction.胰高血糖素样肽-1 及其受体在结构和分子上的保守性赋予了其选择性配体-受体相互作用。
Front Endocrinol (Lausanne). 2012 Nov 19;3:141. doi: 10.3389/fendo.2012.00141. eCollection 2012.
9
Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.在胰高血糖素样肽-1(GLP-1)受体核心处进化上保守的残基赋予配体诱导的受体激活。
J Biol Chem. 2012 Feb 3;287(6):3873-84. doi: 10.1074/jbc.M111.276808. Epub 2011 Nov 21.